MISCELLANEOUS DESIGN

Trademark usage description

pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for the treatment of blood diso Read More

Vienna Information

1 . 7 . 6

Crescent moon, half-moonCroissant, demi-lune

1 . 7 . 19

Several crescents or half-moonsPlusieurs croissants ou demi-lunes

26 . 1 . 2

EllipsesEllipses

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 12

Circles or ellipses containing one or more other geometrical figures -- Note: Including circles or ellipses containing bent or straight lines (except 26.1.10).Cercles ou ellipses contenant une ou plusieurs autres figures géométriques -- Note: Y compris les cercles ou ellipses contenant des lignes courbées ou droites (excepté 26.1.10).

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 5

Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant

Classification Information

Class [005]
Pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; Pharmaceutical preparations for the treatment of alopecia; Pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely atopic dermatitis, Psoriasis; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders, namely lupus; Pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely bone diseases, fibromyalgia; Pharmaceutical preparations for the treatment of cardiovascular diseases, cancer, vascular diseases, metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, hypoglycemia, gout, muscular dystrophy, anemia, metabolic syndrome, and osteoarthritis; Pharmaceutical preparations for the treatment and prevention of migraines, headaches, cluster headaches and pain; Pharmaceutical preparations for the treatment of coronavirus; Pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Parkinson's disease, and multiple sclerosis; Pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's disease, Huntington's disease and cerebral palsy, brain injury, spinal cord injury and seizure disorders; Pharmaceutical preparations for the treatment of mental disorders, namely pharmaceutical preparations for the treatment of dementia and for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, ulcerative colitis, inflammatory tissue diseases; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, Crohn's disease; Pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, obesity, dyslipidemia; Pharmaceutical preparations for the treatment of arthritis, psoriatic arthritis, rheumatoid arthritis; Pharmaceutical preparations for the treatment of cardiovascular diseases, namely heart failure; Pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely menopause, diabetes, Addison's disease, Cushing's disease, Graves' disease, hyperthyroidism, hypothyroidism

Classification kind code

Mark Details

Serial Number

2205730

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 15^th Apr 2025	Approved
Submitted for opposition 27 on 15^th Apr 2025	Approval Notice Sent
Submitted for opposition 22 on 12^th Mar 2025	Search Recorded
Submitted for opposition 20 on 12^th Mar 2025	Examiner's First Report
Submitted for opposition 287 on 1^st Sept 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 24^th Aug 2022	Filed
Submitted for opposition 1 on 24^th Aug 2022	Created
Submitted for opposition 31 on 24^th Aug 2022	Formalized